A purified inactivated Japanese encephalitis virus vaccine made in vero cells

By Srivastava A.K.   Putnak J.R.   Lee S.H.   Hong S.P.   Moon S.B.   Barvir D.A.   Zhao B.   Olson R.A.   Kim S.-O.   Yoo W.-D.   Towle A.C.   Vaughn D.W.   Innis B.L.   Eckels K.H.  

Vaccine, Vol. 19, Iss. 31, 2001-08 ,pp. : 4557-4565

Elsevier

Access to resources Recommend Favorite

Development of a mammalian cell (Vero) derived candidate influenza virus vaccine

By Kistner O.   Barrett P.N.   Mundt W.   Reiter M.   Schober-Bendixen S.   Dorner F.  

Vaccine, Vol. 16, Iss. 9, 1998-05 ,pp. : 960-968

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children

By Halperin S.A.   Smith B.   Mabrouk T.   Germain M.   Trepanier P.   Hassell T.   Treanor J.   Gauthier R.   Mills E.L.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1240-1247

Elsevier

Access to resources Recommend Favorite

Genetic stability of oral polio vaccine prepared on primary monkey kidney cells or Vero cells -- effects of passage in cell culture and the human gastrointestinal tract

By Chezzi C.   Dommann C.J.   Blackburn N.K.   Maselesele E.   McAnerney J.   Schoub B.D.  

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 2031-2038

Elsevier

Access to resources Recommend Favorite

Replicative advantage in tissue culture of egg-adapted influenza virus over tissue-culture derived virus: implications for vaccine manufacture

By Robertson J.S.   Cook P.   Attwell A.-M.   Williams S.P.  

Vaccine, Vol. 13, Iss. 16, 1995-11 ,pp. : 1583-1588

Elsevier

Access to resources Recommend Favorite